Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Holding INSP?
Track your performance easily
INSP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$123.00 - $257.40
Previous CloseN/A
Volume95.34K
Average Volume (3M)585.92K
Market Cap
$5.65B
Enterprise Value$6.08B
Total Cash (Recent Filing)$6.68M
Total Debt (Recent Filing)$12.38M
Price to Earnings (P/E)175.1
Beta0.70
Next Earnings
Feb 10, 2025EPS Estimate
0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.08
Shares Outstanding29,966,913
10 Day Avg. Volume760,939
30 Day Avg. Volume585,919
Standard Deviation0.16
R-Squared0.18
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.47
Price to Cash Flow (P/CF)27.00
P/FCF Ratio31.90
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue8.05
Enterprise Value/Gross Profit11.51
Enterprise Value/Ebitda157.63
Forecast
1Y Price Target
$238.78Price Target Upside26.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Inspire Medical Systems News
PremiumCompany Announcements
Inspire Medical Systems Projects Strong Revenue Growth
Bulls Say, Bears Say
Bulls Say
Market ExpansionINSP activated 72 new centers in the US and created 12 new sales territories, which exceeded expectations.
Product LaunchThe launch of Inspire V can act as a catalyst for shares and drive further utilization improvements as physicians can complete procedures faster.
Revenue GrowthRevenue grew nearly twice as fast as operating expenses in 2024 reflecting impressive leverage.
Bears Say
Financial Guidance And Market ExpectationsThe sell-off in shares was likely due to the mid-point of guidance ($947.5M) being approximately $3M below the street.
Leadership And Strategic DirectionThe departure of Chief Medical Officer Dr. Charisse Sparks may introduce uncertainty in leadership stability and strategic direction.
Market CompetitionThe recent approval of Zepbound for the treatment of moderate-to-severe OSA in patients with obesity may cause potential patients for INSP implants to delay or forego the procedure.
---
Ownership Overview
1.52% Insiders
46.60% Mutual Funds
0.12% Other Institutional Investors
28.87% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INSP FAQ
What was Inspire Medical Systems’s price range in the past 12 months?
Inspire Medical Systems lowest stock price was $123.00 and its highest was $257.40 in the past 12 months.
What is Inspire Medical Systems’s market cap?
Inspire Medical Systems’s market cap is $5.65B.
When is Inspire Medical Systems’s upcoming earnings report date?
Inspire Medical Systems’s upcoming earnings report date is Feb 10, 2025 which is in 14 days.
How were Inspire Medical Systems’s earnings last quarter?
Inspire Medical Systems released its earnings results on Nov 04, 2024. The company reported $0.6 earnings per share for the quarter, beating the consensus estimate of $0.061 by $0.539.
Is Inspire Medical Systems overvalued?
According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued.
Does Inspire Medical Systems pay dividends?
Inspire Medical Systems does not currently pay dividends.
What is Inspire Medical Systems’s EPS estimate?
Inspire Medical Systems’s EPS estimate is 0.73.
How many shares outstanding does Inspire Medical Systems have?
Inspire Medical Systems has 29,966,913 shares outstanding.
What happened to Inspire Medical Systems’s price movement after its last earnings report?
Inspire Medical Systems reported an EPS of $0.6 in its last earnings report, beating expectations of $0.061. Following the earnings report the stock price went up 3.264%.
Which hedge fund is a major shareholder of Inspire Medical Systems?
Among the largest hedge funds holding Inspire Medical Systems’s share is Gilder Gagnon Howe & Co LLC.. It holds Inspire Medical Systems’s shares valued at 47M.
---
Inspire Medical Systems Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$238.78 (26.69% Upside)
$238.78 (26.69% Upside)
Blogger Sentiment
Bullish
INSP Sentiment 80%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 305.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 6.7%
Last 30 Days ▲ 6.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.80%
12-Months-Change
Fundamentals
Return on Equity
5.33%
Trailing 12-Months
Asset Growth
24.50%
Trailing 12-Months
Company Description
Inspire Medical Systems
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
---
INSP Company Deck
---
INSP Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong positive outlook with significant revenue growth, profitability, and expansion, albeit with some minor challenges related to external factors like hurricanes and IV solution shortages impacting the fourth quarter.Read More>---
INSP Revenue Breakdown
97.02% U.S.
2.98% Other
---
INSP Stock 12 Month Forecast
Average Price Target
$238.78
▲(26.69% Upside)
Technical Analysis
Best Analysts Covering INSP
1 Year
1 Year Success Rate
18/29 ratings generated profit
1 Year Average Return
+23.77%
assigned a buy rating 10 days ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 62.07% of your transactions generating a profit, with an average return of +23.77% per trade.
---